In the intricate landscape of healthcare and pharmaceuticals, Form 8947 stands as a vital document for entities involved in the production and importation of branded prescription drugs. Issued by the Department of the Treasury’s Internal Revenue Service, this form serves a critical role in the annual financial disclosures required from manufacturers and importers. Specifically designed for entities to report information concerning sales of branded prescription drugs to specified government programs, Form 8947 has nuanced requirements based on the reporting entity’s history and changes in drug listings. Entities must indicate their status as either first-time filers or subsequent year filers, with further divisions based on whether they have changes to report regarding their drug listings or are reporting on rebates. The form intricately details every aspect of drug information, from National Drug Codes (NDCs) additions and deletions, information on orphan drugs, to Medicaid state supplemental rebates for previously reported NDCs. Through a series of schedules attached to the primary form, entities are required to disclose comprehensive data, including the date of FDA approval for drugs, applicable Medicaid state supplemental rebate amounts, and orphan drug credits allowed per tax year. Understanding and navigating the complexities of Form 8947 is essential for entities within the pharmaceutical sector to maintain compliance and ensure accurate reporting of their branded prescription drug sales.
| Question | Answer |
|---|---|
| Form Name | Form 8947 |
| Form Length | 9 pages |
| Fillable? | No |
| Fillable fields | 0 |
| Avg. time to fill out | 2 min 15 sec |
| Other names | form 8947, 2009, 2010, Deletions |